Companies: 10,795·Total market cap: $144.5T
OPKO Health, Inc.

OPKO Health, Inc.

OPKNASDAQHealthcare● Active
$1.43
$-0.01(-0.69%)
Market Cap$1.1B
P/E Ratio
52W High$1.6
52W Low$0.98

OPKO Health, Inc. (OPK) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

opk · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
4
Sell
1
Strong Sell
0
Total: 13 · Buy rate: 61.5%

12-Month Price Target

High

$4.00

Consensus

$2.87

+99.3% upside

Low

$1.60

Median: $3 · Last Close: $1.44

The OPKO Health, Inc. (OPK) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month OPK price target is $2.87, representing +99.3% upside from the current price of $1.44.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $3 (99.3%)

Consensus Target

$2.87

99.3% upside

High Target

$4

177.8%

Low Target

$1.6

11.1%

Current Price

$1.44

as of today

Based on analyst price targets, the OPK stock price prediction for the next 12 months ranges from $1.6 to $4. The consensus OPK price forecast of $2.87 implies 99.3% upside from the current price of $1.44.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$1.515.00%

1-day model range: $1.5–$1.52. Peak: $1.52 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-14.6%
2028$1-21.5%
2029$1-25.0%
2030$1-26.8%
2031-27.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%7%7%
12Buy
1Neutral
1Sell
RSI (14)81.6Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · OPK · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.44NEUTRAL
MA 10$1.41BUY
MA 20$1.28BUY
MA 50$1.21BUY
MA 100$1.22BUY
MA 200$1.31BUY
Current $OPK · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.43BUY
EMA 10$1.40BUY
EMA 20$1.33BUY
EMA 50$1.25BUY
EMA 100$1.25BUY
EMA 200$1.28BUY
Current $OPK · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barrington Research2026-04-29
Downgrade ↓
OutperformMarket Perform
Barrington Research2026-03-02
Maintains
OutperformOutperform
Jefferies2025-10-31
Downgrade ↓
BuyHold
Barrington Research2025-10-30
Maintains
OutperformOutperform
Barrington Research2025-05-01
Maintains
OutperformOutperform
HC Wainwright & Co.2025-04-07
Maintains
BuyBuy
HC Wainwright & Co.2025-03-19
Maintains
BuyBuy
Barrington Research2025-03-12
Maintains
OutperformOutperform
HC Wainwright & Co.2025-03-12
Maintains
BuyBuy
HC Wainwright & Co.2025-03-03
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on OPKO Health, Inc. (OPK) stock. Of the recent 54 rating actions, 1 were upgrades and 6 were downgrades. 13 analysts currently cover OPK.

Analyst Recommendation Trends

Buy ratings404
Hold ratings01↑ +1
Sell ratings00

OPK analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$538M

↓ 11.7% YoY

Revenue Next Year

$568M

↑ 5.6% YoY

EPS This Year

$-0.31

EPS Next Year

$-0.26

↓ 13.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast OPK EPS of $-0.31 for the current fiscal year, based on estimates from 4 analysts. The OPK revenue forecast is $538M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The OPK stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus OPK price target is $2.87 (+99.3% upside), with an analyst consensus of Buy.

The OPK short-term stock prediction for tomorrow is $1.51 (+5.00%). The OPK stock price prediction for 2027 estimates an average of $1. The OPK stock prediction for 2030 projects a range of $1–$1.

OPKO Health, Inc. trades on NASDAQ under the ticker OPK. The OPK stock outlook for 2027 is broadly positive, supported by a Buy consensus among 62% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

OPK forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month OPK price target is $2.87, with a high forecast of $4.00 and a low of $1.60. The median price target is shown in the chart above when available. This implies +99.3% potential upside from the current price of $1.44.

OPK price targetWhat is OPK price targetOPK analyst price targetOPK 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.